Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. (1995) Association between clozapine response and allelic variation in 5-HT2A receptor genes. Lancet346: 281-282
2.
Bakshi V.P., Geyer M.A. (1995) Antagonism of phencyclidine induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology122: 198-201
3.
Laux G., Kleiser E., Schröder H.G., Dittman V., Unterweger B., Schubert H., König P., Schöny H.W., Bunse J., Beckmann H. (1990) A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia. Acta Psychiat Scand82 (Suppl. 358): 125-129
4.
Nimgaonkar V.L., Zhang X.R., Brar J.S., Deleo M., Ganguli R. (1996) 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiat Genet6: 23-28
5.
Nutt D.J. (1994) Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics? J Psychopharmac8:193-195
6.
Reynolds G.P. (1995) Neurotransmitter systems in schizophrenia. Int Rev Neurobiol38: 305-339
7.
Reynolds G.P. (1996) The importance of dopamine D4 receptors in the action and development of antipsychotic agents. Drugs51: 7-11
8.
Sodhi M.S., Arranz M.J., Ball D., Sham P., Curtis D., Roberts G.W., Price J., Collier D.A., Kerwin R.W. (1995) Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport7:169-172
9.
Soni S.D., Malik A., Schiff A.A. (1990) Sulpiride in negative schizophrenia: a placebo-controlled double-blind assessment. Hum Psychopharmac5: 233-238
10.
Tecott L.H., Sun L.M., Akana S.F., Struch A.M., Lowenstein D.H., Dallman M.F., Julius D. (1995) Eating disorder and epilepsy in mice lacking 5-HT 2C serotonin receptors. Nature374: 542-546
11.
Williams J., Sparlock G., McGuffin P., Mallet J., Nothen M.M., Gill M., Aschauer H., Nylander P.O., Macciarfi F., Owen M.J. (1996) Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet347: 1294-1296
